Science
Mechanism of Action
This ingredient offers antibacterial and antifungal properties by disrupting microbial cell membranes. Research also suggests its potential to mitigate oxidative stress by modulating signaling pathways and preserving antioxidant levels in skin aging models.
Research
Clinical Evidence
Medium confidence0.00063%
Key findings
- 01 Clinical safety evaluations indicate Allylanisole is generally non-sensitizing between 0.1% and 1.5%, though classified as a weak sensitizer in high-dose patch testing. However, IFRA establishes a maximum safe concentration of 0.00063% for facial products to prevent potential genotoxicity and skin sensitization risks.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Stable under standard storage conditions but is highly volatile, requiring airtight, light-protected containers. It can isomerize to anethole when exposed to strong bases.
Conflicts
- Strong oxidizing agents
- Strong bases
- Highly acidic environments
Safety
Safety Profile
While CIR has not issued a standalone review, IFRA restricts its use due to potential genotoxicity concerns. Dermal limits are significantly stricter than its GRAS classification for food, especially in leave-on products.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite potential antioxidant and antimicrobial properties, Allylanisole's use in precision skincare is highly restricted to extremely low concentrations due to genotoxicity concerns.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources